157 related articles for article (PubMed ID: 8508376)
21. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
[TBL] [Abstract][Full Text] [Related]
22. Survival of adults treated for medulloblastoma using paediatric protocols.
Spreafico F; Massimino M; Gandola L; Cefalo G; Mazza E; Landonio G; Pignoli E; Poggi G; Terenziani M; Pedrazzoli P; Siena S; Fossati-Bellani F
Eur J Cancer; 2005 Jun; 41(9):1304-10. PubMed ID: 15869875
[TBL] [Abstract][Full Text] [Related]
23. Modern treatment strategies in medulloblastoma.
Kühl J
Childs Nerv Syst; 1998; 14(1-2):2-5. PubMed ID: 9548331
[TBL] [Abstract][Full Text] [Related]
24. Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma.
Osumi AK; Mclendon RE; Tien RD; Friedman HS; Graham M; Hockenberger B; Halperin EC; Oakes WJ
Clin Neuropathol; 1994; 13(5):281-5. PubMed ID: 7805312
[TBL] [Abstract][Full Text] [Related]
25. Medulloblastoma as a secondary malignancy after radiotherapy-free treatment for acute lymphoblastic leukemia.
Schiavetti A; Clerico A; De Pasquale MD; Bernardini L; Moleti ML
J Pediatr Hematol Oncol; 2003 Jul; 25(7):562-4. PubMed ID: 12847325
[TBL] [Abstract][Full Text] [Related]
26. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
27. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
28. Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
Fouladi M; Chintagumpala M; Ashley D; Kellie S; Gururangan S; Hassall T; Gronewold L; Stewart CF; Wallace D; Broniscer A; Hale GA; Kasow KA; Merchant TE; Morris B; Krasin M; Kun LE; Boyett JM; Gajjar A
J Clin Oncol; 2008 Aug; 26(22):3749-55. PubMed ID: 18669462
[TBL] [Abstract][Full Text] [Related]
29. [High-dose chemotherapy in relapse of medulloblastoma in young children].
Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
[TBL] [Abstract][Full Text] [Related]
30. Timing of radiation in children with medulloblastoma/PNET.
Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM
Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
[TBL] [Abstract][Full Text] [Related]
31. [Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy].
Röttinger EM
Strahlenther Onkol; 1995 Apr; 171(4):247-8. PubMed ID: 7740416
[No Abstract] [Full Text] [Related]
32. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
33. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL
J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503
[TBL] [Abstract][Full Text] [Related]
34. High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031).
Tarbell NJ; Friedman H; Polkinghorn WR; Yock T; Zhou T; Chen Z; Burger P; Barnes P; Kun L
J Clin Oncol; 2013 Aug; 31(23):2936-41. PubMed ID: 23857975
[TBL] [Abstract][Full Text] [Related]
35. Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report.
Kretschmar CS; Tarbell NJ; Kupsky W; Lavally BL; Loeffler JS; Wolfe L; Strand R; Scott RM; Sallan SE
J Neurosurg; 1989 Dec; 71(6):820-5. PubMed ID: 2585072
[TBL] [Abstract][Full Text] [Related]
36. [A patient with lung metastasis of medulloblastoma].
Naitoh T; Matsushita K; Asai Y; Suetsugu S
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Nov; 34(11):1260-3. PubMed ID: 8976084
[TBL] [Abstract][Full Text] [Related]
37. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
38. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
Douglas JG; Barker JL; Ellenbogen RG; Geyer JR
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1161-4. PubMed ID: 15001259
[TBL] [Abstract][Full Text] [Related]
39. Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine.
Levin VA; Rodriguez LA; Edwards MS; Wara W; Liu HC; Fulton D; Davis RL; Wilson CB; Silver P
J Neurosurg; 1988 Mar; 68(3):383-7. PubMed ID: 3343610
[TBL] [Abstract][Full Text] [Related]
40. Successful combination chemotherapy (cisplatinum, vinblastine, and bleomycin) in the treatment of medulloblastoma disseminated by cerebrospinal fluid: case report.
Asai A; Matsutani M; Kohno T; Fujimaki T; Takakura K
Neurosurgery; 1989 Mar; 24(3):439-43. PubMed ID: 2467227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
